This paper assessed the relevance of CD15, CD44, CD133, and α6 integrin, which earlier proved to be convenient for identifying tumor-initiating glioblastoma cells, as glioblastoma stem cell surface markers. This evidence concerns the gene PROM1 and glioblastoma.